TY  - GEN
AU  - Festuccia,Claudio
AU  - Gravina,Giovanni Luca
AU  - D'Alessandro,Anna Maria
AU  - Muzi,Paola
AU  - Millimaggi,Danilo
AU  - Dolo,Vincenza
AU  - Ricevuto,Enrico
AU  - Vicentini,Carlo
AU  - Bologna,Mauro
TI  - Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models
SN  - 1351-0088
PY  - 2009///0716
KW  - Animals
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Apoptosis
KW  - drug effects
KW  - Azacitidine
KW  - Blotting, Western
KW  - Caspase 3
KW  - metabolism
KW  - Cell Proliferation
KW  - Cisplatin
KW  - administration & dosage
KW  - Cyclin D1
KW  - Cyclin-Dependent Kinase Inhibitor p16
KW  - Cyclin-Dependent Kinase Inhibitor p21
KW  - Cyclin-Dependent Kinase Inhibitor p27
KW  - Disease Models, Animal
KW  - Docetaxel
KW  - Drug Synergism
KW  - Drug Therapy, Combination
KW  - Flow Cytometry
KW  - Humans
KW  - Male
KW  - Mice
KW  - Mice, Nude
KW  - Prostatic Neoplasms
KW  - drug therapy
KW  - Proto-Oncogene Proteins c-bcl-2
KW  - Signal Transduction
KW  - Taxoids
KW  - Xenograft Model Antitumor Assays
KW  - bcl-2 Homologous Antagonist-Killer Protein
KW  - bcl-2-Associated X Protein
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1677/ERC-08-0130
ER  -